BCRX - BIOCRYST PHARMACEUTICALS INC
IEX Last Trade
7.71
-0.005 -0.065%
Share volume: 30,171
Last Updated: Fri 27 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$7.72
0.00
-0.06%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-04 | 2023-02-27 | 2023-05-08 | 2023-08-07 | 2023-11-08 | 2024-02-27 | 2024-05-07 | |
| Total revenue | 65.532 M | 75.827 M | 79.545 M | 68.778 M | 82.491 M | 86.742 M | 93.401 M | 92.761 M | |
| Cost of revenue | 246.000 K | 3.543 M | 2.383 M | 931.000 K | 894.000 K | 1.099 M | 1.557 M | 1.265 M | |
| Gross profit | 65.286 M | 72.284 M | 77.162 M | 67.847 M | 81.597 M | 85.643 M | 91.844 M | 91.496 M | |
| 10.72% | 6.75% | -12.07% | 20.27% | 4.96% | 7.24% | -0.38% | |||
| Operating expenses | 100.007 M | 89.659 M | 123.360 M | 96.255 M | 102.244 M | 97.527 M | 134.434 M | 105.857 M | |
| Selling general and admin | 38.017 M | 36.919 M | 50.153 M | 47.867 M | 50.997 M | 50.648 M | 64.382 M | 59.364 M | |
| Research and development | 61.990 M | 52.740 M | 73.207 M | 48.388 M | 51.247 M | 46.879 M | 70.052 M | 46.493 M | |
| Total expenses | 100.254 M | 93.272 M | 125.856 M | 97.193 M | 103.194 M | 98.663 M | 136.071 M | 107.249 M | |
| -6.96% | 34.93% | -22.77% | 6.17% | -4.39% | 37.91% | -21.18% | |||
| Operating income | -34.722 M | -17.445 M | -46.311 M | -28.415 M | -20.703 M | -11.921 M | -42.670 M | -14.488 M | |
| Ebit | -34.722 M | -17.445 M | -46.311 M | -28.415 M | -20.703 M | -11.921 M | -42.670 M | -14.488 M | |
| Pretax income | -58.003 M | -40.998 M | -71.465 M | -52.662 M | -74.586 M | -35.819 M | -63.162 M | -35.014 M | |
| -29.32% | 74.31% | -26.31% | 41.63% | -51.98% | 76.34% | -44.56% | |||
| Income tax | 856.000 K | 1.522 M | 76.000 K | 671.000 K | 740.000 K | 330.000 K | -1.431 M | 365.000 K | |
| Net income basic | -58.859 M | -42.520 M | -71.541 M | -53.333 M | -75.326 M | -36.149 M | -61.731 M | -35.379 M | |
| 27.76% | -68.25% | 25.45% | -41.24% | 52.01% | -70.77% | 42.69% | |||
| Net income | -58.859 M | -42.520 M | -71.541 M | -53.333 M | -75.326 M | -36.149 M | -61.731 M | -35.379 M | |
| 27.76% | -68.25% | 25.45% | -41.24% | 52.01% | -70.77% | 42.69% |